Pretreatment serum VEGF is associated with clinical response and overall survival in advanced melanoma patients treated with ipilimumab.

Yuan, Jianda; Zhou, Jun; Dong, Zhiwan; Tandon, Sapna; Kuk, Deborah; Panageas, Katherine S; Wong, Philip; Wu, Xinqi; Naidoo, Jarushka; Page, David B; Wolchok, Jedd D; Hodi, F Stephen

Yuan, Jianda; Zhou, Jun; Dong, Zhiwan; Tandon, Sapna; Kuk, Deborah; Panageas, Katherine S; Wong, Philip; Wu, Xinqi; Naidoo, Jarushka; Page, David B; Wolchok, Jedd D; Hodi, F Stephen.

Affiliation

Yuan J; Authors' Affiliations Melanoma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

Cancer Immunol Res ; 2(2): 127-32, 2014 02.

Article in En | MEDLINE | ID: mdl-24778276

Subject(s)

Antibodies, Monoclonal/therapeutic use; Antineoplastic Agents/therapeutic use; Biomarkers, Tumor/blood; Melanoma/drug therapy; Skin Neoplasms/drug therapy; Vascular Endothelial Growth Factor A/blood; Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal/administration & dosage; Antineoplastic Agents/administration & dosage; Dose-Response Relationship, Drug; Female; Humans; Ipilimumab; Kaplan-Meier Estimate; Male; Melanoma/blood; Middle Aged; Prognosis; Skin Neoplasms/blood; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Biomarkers, Tumor / Vascular Endothelial Growth Factor A / Melanoma / Antibodies, Monoclonal / Antineoplastic Agents Type of study: Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Immunol Res Year: 2014 Document type: Article

Fulltext

XML

PubMed Links

Search on Google